DK614987D0 - Syntetiske htlv-iii peptider, praeparater og anvendelser deraf - Google Patents

Syntetiske htlv-iii peptider, praeparater og anvendelser deraf

Info

Publication number
DK614987D0
DK614987D0 DK614987A DK614987A DK614987D0 DK 614987 D0 DK614987 D0 DK 614987D0 DK 614987 A DK614987 A DK 614987A DK 614987 A DK614987 A DK 614987A DK 614987 D0 DK614987 D0 DK 614987D0
Authority
DK
Denmark
Prior art keywords
preparations
applications
htlv
iii peptides
synthetic
Prior art date
Application number
DK614987A
Other languages
English (en)
Other versions
DK614987A (da
DK175901B1 (da
Inventor
Jonathan I Rosen
Robert B Naso
Ralph B Arlinghaus
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25289969&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK614987(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of DK614987A publication Critical patent/DK614987A/da
Publication of DK614987D0 publication Critical patent/DK614987D0/da
Application granted granted Critical
Publication of DK175901B1 publication Critical patent/DK175901B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
DK198706149A 1986-03-24 1987-11-23 Syntetiske HTLV-III peptider, sammensætninger, anvendelser samt fremgangsmåde til fremstilling deraf DK175901B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US84343786A 1986-03-24 1986-03-24
US84343786 1986-03-24
PCT/US1987/000577 WO1987006005A1 (en) 1986-03-24 1987-03-20 Synthetic htlv-iii peptides, compositions and uses thereof
US8700577 1987-03-20

Publications (3)

Publication Number Publication Date
DK614987A DK614987A (da) 1987-11-23
DK614987D0 true DK614987D0 (da) 1987-11-23
DK175901B1 DK175901B1 (da) 2005-05-30

Family

ID=25289969

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198706149A DK175901B1 (da) 1986-03-24 1987-11-23 Syntetiske HTLV-III peptider, sammensætninger, anvendelser samt fremgangsmåde til fremstilling deraf

Country Status (8)

Country Link
EP (1) EP0261224B2 (da)
JP (1) JPS63502904A (da)
AT (1) ATE98376T1 (da)
AU (3) AU7234387A (da)
DE (1) DE3788397T3 (da)
DK (1) DK175901B1 (da)
WO (1) WO1987006005A1 (da)
ZA (1) ZA872166B (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
AU1334588A (en) * 1987-03-23 1988-09-22 Ortho Pharmaceutical Corporation Assay for detecting hepatitis antigens and aids antibodies
NO881151L (no) * 1987-03-27 1988-09-28 Syntello Ab Syntetisk hiv-1-antigen.
FI872409A0 (fi) * 1987-05-29 1987-05-29 Labsystems Oy Foerfarande foer detektering av hiv-1 motkroppar.
AU623097B2 (en) * 1987-10-09 1992-05-07 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Oligopeptides and their use for diagnostic and vaccination purposes for aids and arc
SE8704185L (sv) * 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser
AU627701B2 (en) * 1987-10-28 1992-09-03 Euro-Diagnostica Ab Hiv peptides, artificial hiv antigens and immunoassay kits
EP0323157A3 (en) * 1987-12-24 1990-07-25 The University Of Melbourne Antiviral compounds and methods
SE8705197D0 (sv) * 1987-12-30 1987-12-30 Jonas Blomberg New peptides, two diagnostic methods using the peptides and a medicament based on the peptides
US6218102B1 (en) 1988-01-27 2001-04-17 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US5241047A (en) * 1988-12-08 1993-08-31 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6210874B1 (en) 1988-01-27 2001-04-03 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6214537B1 (en) 1988-01-27 2001-04-10 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
EP0328390B1 (en) * 1988-02-10 1994-09-14 Immulogic Pharmaceutical Corporation Peptide treatment of refractory infectious diseases
EP0330359A3 (en) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Composition useful in the diagnosis and treating of hiv-1 infection
FR2629459B1 (fr) * 1988-04-01 1990-12-21 Pasteur Institut Peptides pf11 a pf19 d'un retrovirus hiv - procede de synthese de ces peptides - leur utilisation notamment pour le diagnostic
US5268299A (en) * 1988-04-14 1993-12-07 Eastman Kodak Company Diluent composition useful in the detection of antibodies in assays
US5077198A (en) * 1988-04-14 1991-12-31 Eastman Kodak Company Diagnostic kit and method for rapid detection of antibodies
EP0362910A3 (en) * 1988-08-27 1991-01-09 Akzo N.V. Synthetic peptides immunochemically reactive with hiv-antibodies
US5260189A (en) * 1988-12-20 1993-11-09 Immunodiagnostics, Inc. Synthetic HIV-like peptides their compositions and uses
ATE162799T1 (de) * 1989-06-02 1998-02-15 Genetic Systems Corp Peptide mit thiolgeschütztem cystein zur verwendung in immuntests
US5439792A (en) * 1989-06-02 1995-08-08 Genetic Systems Corporation Cysteine thiol-protected peptides for use in immunoassays
US5459060A (en) * 1989-08-24 1995-10-17 Bioclonetics Incorporated Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1)
US6083504A (en) * 1989-08-24 2000-07-04 Bioclonetics Incorporated Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1)
US6248574B1 (en) 1989-12-13 2001-06-19 Avigdor Shaffermann Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides
FR2657017B1 (fr) * 1990-01-16 1995-08-18 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-1, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
EP0438332B1 (fr) * 1990-01-16 1998-04-08 Orgenics Ltd. Peptides dérivant de la glycoprotéine d'enveloppe de virus HIV, leurs applications à la détection d'une infection due à ces virus et à la vaccination contre le SIDA
DE69326069T2 (de) * 1992-07-20 2000-03-23 Univ Durham Zusammensetzungen die die hiv replikation inhibieren
CA2125467C (en) * 1993-07-06 2001-02-06 Heinz Dobeli Process for producing hydrophobic polypeptides, proteins or peptides
FR2732346B1 (fr) * 1995-03-27 1997-05-30 Centre Nat Rech Scient Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications
DE19720914A1 (de) * 1997-05-16 1998-11-19 Boehringer Mannheim Gmbh Verfahren zum Nachweis von HIV-Antikörpern und dazu verwendete Antigene
WO2010085763A1 (en) * 2009-01-23 2010-07-29 Inova Diagnostics, Inc. Methods for detecting antibodies associated with autoimmune diseases utilizing a three dimensionally heterogeneous peptide antigen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4134792A (en) * 1976-12-06 1979-01-16 Miles Laboratories, Inc. Specific binding assay with an enzyme modulator as a labeling substance
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
JP2705791B2 (ja) * 1985-04-29 1998-01-28 ジエネテイツク システムズ コ−ポレイシヨン Aids関連病の検出のための合成抗原
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法

Also Published As

Publication number Publication date
AU1130392A (en) 1992-06-04
EP0261224B1 (en) 1993-12-08
EP0261224A1 (en) 1988-03-30
DK614987A (da) 1987-11-23
JPS63502904A (ja) 1988-10-27
ZA872166B (en) 1988-10-26
DE3788397T2 (de) 1994-06-01
AU7234387A (en) 1987-10-20
DK175901B1 (da) 2005-05-30
AU8172094A (en) 1995-03-23
EP0261224B2 (en) 2003-03-26
ATE98376T1 (de) 1993-12-15
DE3788397D1 (de) 1994-01-20
DE3788397T3 (de) 2003-11-27
EP0261224A4 (en) 1989-07-06
WO1987006005A1 (en) 1987-10-08

Similar Documents

Publication Publication Date Title
DK614987A (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
DK626486D0 (da) Syntetiske antigener til afslaering af aids-relateret sygdom
EA199800946A1 (ru) Концентрированный препарат антител
DK93388A (da) Lav-virusvarianter, dna- og proteinbestanddele deraf og anvendelse deraf, saerlig til diagnostiske formaal og til fremstilling af immunogene praeparater
KR890002547A (ko) Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드
DK101888D0 (da) Immunmodulerende midler og anvendelse af disse
ATE231557T1 (de) Detektion des hepatis-c virus.
DK235687A (da) Tilberedninger til syntese af prostaglandiner og hydroxyfedtsyrer i biologiske systemer og anvendelse deraf
DE3872754D1 (de) Nachweis von antikoerpern humaner immundefizienz-viren.
IT1207589B (it) Composizione di anticorpi monoclonali umani cross-protettivi.
ES2080047T3 (es) Peptidos hiv y metodos para la deteccion de hiv.
FI872576A0 (fi) Peptider med inverkan pao diures och natriures, foerfarande foer framstaellning av dessa och medel innehaollande dessa och deras anvaendning.
NO920942D0 (no) Konjugert vaksine for gruppe b streptococcus
KR890700683A (ko) 인체 면역 결핍 바이러스에 대한 항체 검색 방법
FI874273A (fi) Uudet monoklonaaliset vasta-aineet IFN-omegalle, niiden valmistusmenetelmät ja niiden käyttö IFN-omegan puhdistamiseen ja osoittamiseen
DK319384A (da) 1-0-alkyl-3-amino-propan-1,2-diol-2-0-phospholipider, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse
ES2056872T3 (es) Proteina pp4-x anticoagulante, su preparacion y empleo.
NO870779L (no) Opploeseliggjoering av proteiner for farmasoeytiske preparater ved bruk av polymerkonjugasjon.
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов
IT1213576B (it) Composizione polipeptidica utile per la preparazione di vaccini antimalaria e di kits diagnostici per la determinazione di anticorpi antimerozoite.
DE3788424D1 (de) Testverfahren des menschlichen b-lymphotropen virus (hblv).
ES2155436T3 (es) Proteinas recombinantes con la reactividad inmunologica del antigeno e del virus de la hepatitis b (hbeag), procedimiento para su preparacion y su utilizacion en analisis inmunologicos y en vacunas.
ATE98379T1 (de) Testverfahren des menschlichen b-lymphotropen virus (hblv).

Legal Events

Date Code Title Description
PUP Patent expired